<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: MicroRNAs (miRNAs) are small, non-coding <z:chebi fb="40" ids="33697">RNA</z:chebi> segments that regulate gene expression via post-transcriptional inhibition and have roles in cell differentiation, proliferation, and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Expression differs between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and <z:mpath ids='MPATH_458'>normal</z:mpath> tissue in several <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Most work has focused on tissue and cell expression with few reports of circulating miRNAs in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Available biomarkers for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> have limited sensitivity and specificity, thus there is a need for new markers </plain></SENT>
<SENT sid="4" pm="."><plain>AIMS: This study aimed to identify miRNAs that are differentially expressed in the blood of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients compared to controls and to establish if this is specific to <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and thus could be utilized as potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> markers </plain></SENT>
<SENT sid="5" pm="."><plain>METHODS: Blood samples were collected from 63 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and 45 controls </plain></SENT>
<SENT sid="6" pm="."><plain>Expression of 7 target miRNAs (miR-143, miR-145, miR-21, miR-30a-3p, miR-31, miR-34a, and miR-92) was measured using RQ-PCR </plain></SENT>
<SENT sid="7" pm="."><plain>Results were correlated with clinicopathological data and analyzed </plain></SENT>
<SENT sid="8" pm="."><plain>Analysis of differentially expressed circulating miRNAs was expanded to include 62 patients with prostate, renal, breast, and <z:hpo ids='HP_0002861'>melanoma</z:hpo> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Analysis of the relative quantification of the target miRNAs showed significantly reduced expression (P = 0.004) of miR-34a in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>MiR-34a was also significantly reduced in <z:hpo ids='HP_0003002'>breast cancer</z:hpo> (P = 0.019) </plain></SENT>
<SENT sid="11" pm="."><plain>CONCLUSION: This study demonstrates significantly reduced expression of circulating miR-34a in colorectal and <z:hpo ids='HP_0003002'>breast cancer</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>This may have future application as part of a biomarker profile </plain></SENT>
</text></document>